Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Leukoc Biol ; 78(1): 202-9, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15788441

RESUMEN

Human mononuclear phagocytes have recently been shown to express constitutively and even more so, upon stimulation with bacteria, fungi, lipopolysaccharide (LPS), zymosan, or thrombin platelet basic protein (PBP). This CXC chemokine as well as platelet factor 4 (PF4), which is located genomically at a short distance from the PBP, were previously considered to be specific markers for the megakaryocyte cell lineage. Both chemokines have signaling and antimicrobial activity. In the present studies, transcriptional and expressional regulation of PF4 and related chemokines was studied in human monocytes. As shown by quantitative mRNA analysis, Western blots, radioimmunoprecipitation of cell extracts, and immunofluorescence and quantitatively with enzyme-linked immunosorbent assay, human monocytes express PF4 in the same order of magnitude as the known, regulated CXC chemokine interleukin (IL)-8. Expression of PF4 is up-regulated at the mRNA and protein level by thrombin and mediated by proteinase-activated receptors (PARs), resulting in a 32- to 128-fold higher mRNA level and leading to an up-to-sixfold increase of the peptide concentration in monocyte culture supernatants. Thrombin and the synthetic ligand of PAR-1 and PAR-2, SFLLRN, also induced comparable increases in the levels of mRNA for PBP, IL-8, regulated on activation, normal T expressed and secreted (RANTES), monocyte chemoattractant protein-1, and macrophage-inflammatory protein-1alpha and increased synthesis of these chemokines as shown by immunofluorescence or a quantitative immunobead-based method. The induction of increased mRNA levels for all chemokines by SFLLRN was unsurpassed by LPS, zymosan, interferon-gamma (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), and IL-1. Activation of monocytes through PARs represents an alternate activation mechanism, independent from IFN-gamma, TNF-alpha, or other signaling pathways.


Asunto(s)
Quimiotaxis de Leucocito/inmunología , Monocitos/inmunología , Factor Plaquetario 4/inmunología , Receptores Proteinasa-Activados/inmunología , Transducción de Señal/inmunología , Células Cultivadas , Quimiocina CCL2/efectos de los fármacos , Quimiocina CCL2/inmunología , Quimiocina CCL4 , Quimiocina CCL5/inmunología , Quimiocinas CXC/inmunología , Quimiotaxis de Leucocito/efectos de los fármacos , Humanos , Mediadores de Inflamación/farmacología , Interleucina-8/inmunología , Interleucina-8/metabolismo , Proteínas Inflamatorias de Macrófagos/inmunología , Monocitos/efectos de los fármacos , Monocitos/metabolismo , Fragmentos de Péptidos/farmacología , Factor Plaquetario 4/genética , ARN Mensajero/metabolismo , Receptor PAR-1/efectos de los fármacos , Receptor PAR-1/inmunología , Receptor PAR-2/efectos de los fármacos , Receptor PAR-2/inmunología , Receptores Proteinasa-Activados/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Trombina/metabolismo , Activación Transcripcional/genética , Regulación hacia Arriba/efectos de los fármacos , Regulación hacia Arriba/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA